Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Chinook Therapeutics, Inc. - Common Stock (NQ:KDNY)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 10, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Chinook Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Stocks Sport Midday Leads As Busy Week Begins
Stocks are modestly higher this afternoon amid hopes of a dovish Fed, with the central bank's policy decision due out Wednesday. 
Via Talk Markets
Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Asset Entities Inc. (NASDAQ: ASST) shares jumped 142% to $2.79 after the company announced the development of an AI bot as part of its AE360DDM suite of services on Discord. 
Via Benzinga
What 6 Analyst Ratings Have To Say About Chinook Therapeutics
 
Via Benzinga
What To Know About Guggenheim's Downgrade of Chinook Therapeutics
 
Via Benzinga
Health Care Company Novartis Announces Merger With Chinook Therapeutics
 
Via Benzinga
Why Shares of Chinook Therapeutics Skyrocketed On Monday
The company, which specializes in treating kidney diseases, agreed to a buyout offer. 
Via The Motley Fool
Crude Oil Drops Sharply; Chinook Therapeutics Shares Spike Higher
U.S. stocks traded higher midway through trading, with Dow Jones gaining over 40 points on Monday. The Dow traded up 0.12% to 33,919.07 while the NASDAQ rose 0.49% to 13,323.71. The S&P 500, also rose,... 
Via Benzinga
Chinook Therapeutics Launches Almost 60% On Novartis' $3.5 Billion Takeover
Novartis will pay $3.5 billion to buy the kidney disease-focused biotech company. 
Via Investor's Business Daily
XPeng's New EV Is a Hit, but This Biotech Stock Is Leaving It in the Dust
Find out more about two big winners Monday morning. 
Via The Motley Fool
US Stocks Open Higher; Nasdaq Rises Over 50 Points
U.S. stocks traded higher this morning, with Nasdaq Composite gaining over 50 points on Monday. Following the market opening Monday, the Dow traded up 0.21% to 33,948.78 while the NASDAQ rose 0.47% to... 
Via Benzinga
Broadcom Might Receive European Approval For $61B VMware Deal, UBS Closes Credit Suisse Takeover, Illumina CEO Steps Down Amid Activist Investor Carl Icahn's Pressure: Today's Top Stories
Reuters Broadcom Most Likely To Receive EU Approval For $61B VMware Merger 
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Chinook Therapeutics, Inc. (Nasdaq – KDNY), Franchise Group, Inc. (Nasdaq – FRG), CIRCOR International, Inc. (NYSE - CIR), Greenhill & Co., Inc. (NYSE – GHL)
From Brodsky & Smith LLC
Via GlobeNewswire
Why Is Oncorus (ONCR) Stock Down 27% Today?
Oncorus (ONCR) stock is taking a beating on Monday after revealing plans for a vote during an upcoming special shareholder meeting. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Why Is Chinook Therapeutics (KDNY) Stock Up 58% Today?
Chinook Therapeutics (KDNY) stock is rocketing higher on Monday after the company announced it's being acquired by Novartis AG (NVS). 
Via InvestorPlace
Why Oncorus Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving Premarket
Gainers Auddia Inc. (NASDAQ: AUUD) shares rose 103.2% to $0.8809 in pre-market trading after gaining around 9% on Friday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday morning! 
Via InvestorPlace
Why Are Chinook Therapeutics Shares Trading Higher Today
Novartis AG (NYSE: NVS) has agreed to acquire Chinook Therapeutics Inc (NASDAQ: KDNY) for $40 per share in cash,  
Via Benzinga
KDNY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Chinook Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Nasdaq, S&amp;P 500 Futures Signal Strong Start To Week On Hopes Of Fed Pause: Why This Analyst Is Pricing In A 20% Gain From Bear Market Low
 
Via Benzinga
Chinook Therapeutics, Oracle And Other Big Stocks Moving Higher In Monday's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. Chinook Therapeutics, Inc. (NASDAQ: KDNY) shares jumped 66.8% to $40.01 in... 
Via Benzinga
Bragar Eagel & Squire, P.C. Is Investigating JinkoSolar, Integra, and Chinook and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
KDNY INVESTOR NEWS: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Chinook Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – KDNY
From The Rosen Law Firm PA
Via GlobeNewswire
NASDAQ:KDNY Investor Notice: Investigation over Potential Securities Laws Violations by Chinook Therapeutics, Inc.
San Diego, CA -- (SBWIRE) -- 06/01/2023 -- Chinook Therapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
Bragar Eagel & Squire, P.C. Is Investigating Integra, and Chinook and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
CHINOOK ALERT: Bragar Eagel & Squire, P.C. is Investigating Chinook Therapeutics, Inc. on Behalf of Chinook Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Chinook Therapeutics, Inc. (KDNY) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Chinook Therapeutics, Inc. (KDNY) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Chinook Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Chinook Therapeutics, Inc. (KDNY) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.